Aquatic Capital Management LLC Collegium Pharmaceutical, Inc Transaction History

Aquatic Capital Management LLC

  • $3.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$31.23 - $40.91 $274,824 - $360,007
8,800 New
8,800 $341,000
Q2 2023

Aug 14, 2023
SELL
$21.06 - $24.0 $67,392 - $76,800
-3,200 Reduced 36.36%
5,600 $120,000
Q1 2023

May 15, 2023
BUY
$23.0 - $29.88 $202,400 - $262,944
8,800 New
8,800 $211,000
Q1 2022

May 16, 2022
SELL
$17.2 - $22.5 $6,880 - $9,000
-400 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$17.5 - $21.35 $7,000 - $8,540
400 New
400 $7,000

Others Institutions Holding COLL

# of Institutions
254
Shares Held
36.9M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.12B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email